CLIP
Pro-life group says lack of abortion drug commitments drove opposition to Overton’s failed FDA bid
Erik Baptist, senior vice president of legal strategy at Susan B. Anthony Pro-Life America, explains why the group opposed Heidi Overton’s FDA confirmation.
Erik Baptist, senior vice president of legal strategy at Susan B. Anthony Pro-Life America, explains why the group opposed Heidi Overton’s FDA confirmation without commitments from the Trump administration to restore in-person dispensing requirements for abortion drugs and address concerns about the agency’s mifepristone safety study.
